Arlington Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-58
| Closed | -$27.4K | – | 113 |
|
|
2023
Q4 | $27.4K | Buy |
+58
| New | +$27.4K | 0.01% | 169 |
|
|
2023
Q3 | – | Sell |
-978
| Closed | -$435K | – | 472 |
|
|
2023
Q2 | $435K | Buy |
978
+21
| +2% | +$9.33K | 0.07% | 96 |
|
|
2023
Q1 | $440K | Buy |
957
+70
| +8% | +$32.2K | 0.06% | 87 |
|
|
2022
Q4 | $455K | Hold |
887
| – | – | 0.07% | 66 |
|
|
2022
Q3 | $403K | Hold |
887
| – | – | 0.16% | 66 |
|
|
2022
Q2 | $428K | Hold |
887
| – | – | 0.14% | 73 |
|
|
2022
Q1 | $436K | Hold |
887
| – | – | 0.12% | 75 |
|
|
2021
Q4 | $411K | Buy |
887
+58
| +7% | +$26.9K | 0.11% | 76 |
|
|
2021
Q3 | $309K | Buy |
+829
| New | +$309K | 0.09% | 82 |
|
|
2020
Q3 | – | Sell |
-13
| Closed | -$3K | – | 145 |
|
|
2020
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 147 |
|
|
2020
Q1 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 218 |
|